Dynamics of cell-associated viremia and antibody response during the early phase of lentivirus infection in sheep

American Journal of Veterinary Research

Volumn 59, Issue 5, 1998, Pages 563-568

  Juste, R A ^a,c   Kwang, J ^b,d   De La Concha Bermejillo, A ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b U S MEAT ANIMAL RESEARCH CENTER   (United States)

^c NEIKER and a Vaccine producing Commercial Company CZVSL   (Spain)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN; VIRUS ANTIBODY;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAPRINE ARTHRITIS ENCEPHALITIS VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOLOGY; MALE; MONONUCLEAR CELL; NEWBORN; PHYSIOLOGY; RETROVIRUS INFECTION; SERODIAGNOSIS; SHEEP; SHEEP DISEASE; VIREMIA; VIROLOGY; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; LENTIVIRUS INFECTIONS; LENTIVIRUSES, OVINE-CAPRINE; LEUKOCYTES, MONONUCLEAR; MALE; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS; SHEEP; SHEEP DISEASES; VIRAL LOAD; VIREMIA; VIRUS REPLICATION;

EID: 0032063571     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. de la Concha-Bermejillo A. Maedi-visna and ovine progressive pneumonia. Vet Clin North Am Food Anim Pract 1997;13:13-33.
2. Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993;57:183-289.
3. Stott J, Almond N. Assessing animal models for AIDS. Nature Med 1995;1:295-297.
4. de la Concha-Bermejillo A, Juste RA, Kretschmer R, et al. Ovine lentivirus infection: an animal model for pediatric HIV infection. Arch Med Res 1995;26:345-354.
5. Cutlip RC, Lehmkuhl HD, Schmerr MJ, et al. Ovine progressive pneumonia (maedi-visna) in sheep. Vet Microbiol 1988;17: 237-250.
6. Clements JE, Zink MC. Molecular biology and pathogenesis of animal lentivirus infections. Clin Microbiol Rev 1996;9:100-117.
7. Gendelman HE, Narayan O, Molineaux S, et al. Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. Proc Natl Acad Sci U S A 1985;82:7086-7090.
8. Davis JL, Clements JE. Complex gene expression of lentiviruses. Microb Pathog 1988;4:239-245.
9. Clements JE, Zink MC, Narayan O, et al. Lentivirus infection of macrophages. Immunol Series 1994;60:589-600.
10. Staskus KA, Couch L, Bitterman P, et al. In situ amplification of visna virus DNA in tissue sections reveals a reservoir of latently infected cells. Microb Pathog 1991;11:67-76.
11. Sihvonen L. Early immune responses in experimental maedi. Res Vet Sci 1981;30:217-222.
12. Daar ES, Moudgil T, Meyer RD, et al. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. New Engl J Med 1991;324:961-964.
13. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. New Engl J Med 1993;328:327-335.
14. Pantaleo G, Graziosi C, Fauci AS. The role of lymphoid organs in the pathogenesis of HIV infection. Immunology 1993;5: 157-163.
15. Pantaleo G, Graziosi C, Demarest JF, et al. HIV is active and progressive in lymphoid tissue during the clinical latent stage of disease. Nature 1993;362:355-358.
16. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus Type-1 syndrome. J Virol 1994;68:4650-4655.
17. Gudnadottir M, Palsson P. Successful transmission of visna by intrapulmonary inoculation. J Infect Dis 1965;115:217-225.
18. Nathanson N, Panitch H, Petursson G. Pathogenesis of visna: review and speculation. In: Kimberlin R, ed. Slow virus diseases of animals and man. Oxford: North Holland, 1976;115-131.
19. Petursson G, Nathanson N, Georgsson G, et al. Pathogenesis of visna. I. Sequential virologie, serologic and pathologic studies. Lab Invest 1976;35:402-412.
20. Sihvonen L, Estola T, Tuomi J. Experimental maedi infection in sheep. I. Detection of virus, clinical course, histopathology. Acta Vet Scand 1980;21:113-123.
21. Lairmore MD, Poulson JM, Adducci TA, et al. Lentivirus-induced lymphoproliferative disease. Comparative pathogenicity of phenotypically distinct ovine lentivirus strains. Am J Pathol 1988; 130:80-90.
22. Kwang J, Keen J, Cutlip RC, et al. Evaluation of an ELISA for detection of ovine progressive pneumonia antibodies using a recombinant transmembrane envelope protein. J Vet Diagn Invest 1993; 5:189-193.
23. Kwang J, Cutlip R. Analysis of antibody response to ovine lentivirus by using viral gene products expressed in a prokaryotic system. Biochem Biophys Res Commun 1992;188:20-27.
24. McGuire TC, Norton LK, O'Rourke KI, et al. Antigenic variation of neutralizing sensitive epitopes of caprine-arthritis encephalitis lentivirus during persistent arthritis. J Virol 1988;62:3488-3492.
25. Baltimore D. The enigma of HIV infection. Cell 1995;82: 175-176.
26. Johnson LK, Meyer AL, Zink MC. Detection of ovine lentivirus in seronegative sheep by in situ hybridization, PCR, and cocultivation with susceptible cells. Clin Immunol Immunopathol 1992; 65:254-260.
27. Pantaleo G, Demarest JF, Soudeyns H, et al. Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 1994;370:463-467.
28. Peluso R, Haase AT, Stowring L, et al. A Trojan horse mechanisms for the spread of visna virus in monocytes. Virology 1985;147:231-236.
29. Paxton WA, Koup RA. Mechanisms of resistance to HIV infection. Springer Semin Immunopathol 1997;18:323-340.
30. Petursson G, Andresdottir V, Andresson OS, et al. Lentivirus diseases of sheep and goats: maedi-visna and caprine arthritis encephalitis. In: Speedy AW, ed. Progress in sheep and goat research. Walingford, United Kingdom: CAB International, 1992;107-129.
31. Klein JR, Martin J, Griffing S, et al. Precipitating antibodies in experimental visna and natural progressive pneumonia of sheep. Res Vet Sci 1985;38:129-133.
32. Kennedy-Stoskopf S, Narayan O. Neutralizing antibodies to visna lentivirus: mechanisms of action and possible role in virus persistance. J Virol 1986;59:37-44.
33. Schonning K, Nielsen C, Iversen J, et al. Neutralizing antibodies in slowly progressing HIV-1 infections. J Acquir Immune Defic Synd Human Retrovirol 1995;10:400-407.
34. Narayan O, Zink MC, Huso D, et al. Lentivirus of animals are biological models of the human immune deficiency viruses. Microb Pathog 1988;5:149-157.
35. Kwang J, Kim HS, Rosati S, et al. Characterization of ovine lentivirus envelope glycoprotein expressed in Escherichia coli cell and baculovirus systems. Vet Immunol Immunopathol 1995;45:185-193.
36. Bird P, Blacklaws B, Reyburn HT, et al. Early events in immune evasion by the lentivirus maedi-visna occurring within infected lymphoid tissue. J Virol 1993;67:5187-5197.
37. de la Concha-Bermejillo A, Brodie SJ, Magnus-Corral S, et al. Pathologic and serologic responses of isogeneic twin lambs to phenotypically distinct lentiviruses. J Acquir Immune Defic Synd Human Retrovirol 1995;8:116-123.
38. Kajikawa O, Lairmore MD, DeMartini JC. Analysis of antibody responses to phenotypically distinct lentiviruses. J Clin Microbiol 1990;28:764-770.
39. Moore JP, Cao Y, Ho DD, et al. Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1. J Virol 1994;68:5142-5155.
40. Whetstone CA, VanDerMaaten MJ, Black JW. Humoral immune response to the bovine immunodeficiency-like virus in experimentally and naturally infected cattle. J Virol 1990;64:3557-3561.
41. Kwang J, Rosati S, Yang S, et al. Recognition of ovine lentivirus gag gene products by serum from infected sheep. Vet Immunol Immunopathol 1996;55:107-114.
42. Lairmore MD, Akita GY, Russell HI, et al. Replication and cytopathic effects of ovine lentivirus strains in alveolar macrophages correlate with in vivo pathogenicity. J Virol 1987;61:4038-4042.
43. Tersmette M, Gruters RA, de Wolf F, et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J Virol 1989;63:2118-2125.
44. Tersmette M, Lange JM, De Goede RE, et al. Association between biological properties of human immunodeficiency virus variant and risk for AIDS and AIDS mortality. Lancet 1989;1:983-985.
45. Brodie SJ, Marcom KA, Pearson LD, et al. Effects of virus load in the pathogenesis of lentivirus-induced lymphoid interstitial pneumonia. J Infect Dis 1992;166:531-541.
46. de la Concha-Bermejillo A, Magnus-Corral S, Brodie SJ, et al. Shedding of ovine lentivirus in the semen of infected rams. Am J Vet Res 1996;57:684-688.
47. Ho DD. Viral counts count in HIV infection. Science 1996; 272:1124-1125.
48. Mellors JW, Rinaldo CR, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-1170.
49. Schechter MT, Neumann PW, Weaver MS, et al. Low HIV-1 proviral DNA burden detected by negative polymerase chain reaction in seropositive individuals correlates with slower disease progression. AIDS 1991;5:373-379.
50. Galetto-Lacour A, Yerly S, Perneger TV, et al. Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV cohort study group. J Inject Dis 1996;173:1388-1393.
51. Goedert JJ. Prognostic markers for AIDS. Ann Epidemiol 1990;1:129-139.